Genscript Biotech (GNNSF, $1.05) lost -4 over the last three months. By comparison, the broader Biotechnology Industry returned 3 over the same period. A.I.dvisor analyzed 896 stocks in the Biotechnology Industry over the last three months, and found that of them (3) exhibited an Uptrend while of them (6) experienced a Downtrend. A.I.dvisor found 348 similar cases when GNNSF's price dropped within three months. In of those 348 cases, GNNSF's price went up during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend reversal for GNNSF are